These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9488046)

  • 1. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
    Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
    Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
    Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
    Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenopus laevis TRK-fused gene (TFG) is an SH3 domain binding protein highly expressed in the cement gland.
    Ohan N; Sabourin D; Booth RA; Liu XJ
    Mol Reprod Dev; 2000 Jul; 56(3):336-44. PubMed ID: 10861999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G
    Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.
    Roccato E; Miranda C; Raho G; Pagliardini S; Pierotti MA; Greco A
    J Biol Chem; 2005 Feb; 280(5):3382-9. PubMed ID: 15557341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).
    Zhen Z; Giordano S; Longati P; Medico E; Campiglio M; Comoglio PM
    Oncogene; 1994 Jun; 9(6):1691-7. PubMed ID: 8183564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA
    Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurotrophins. I: Molecular features].
    Zazpe A; Del Río J
    Rev Med Univ Navarra; 1997; 41(3):173-9. PubMed ID: 10420923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors.
    Schneider R; Schweiger M
    Oncogene; 1991 Oct; 6(10):1807-11. PubMed ID: 1656363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.
    Roccato E; Miranda C; Ranzi V; Gishizki M; Pierotti MA; Greco A
    Br J Cancer; 2002 Sep; 87(6):645-53. PubMed ID: 12237775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
    Ranzi V; Meakin SO; Miranda C; Mondellini P; Pierotti MA; Greco A
    Endocrinology; 2003 Mar; 144(3):922-8. PubMed ID: 12586769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.